Source / episode info
- **Episode:**567
- **Title:**DIP Ep 567: 2024 USMLE Step 3 Free 137 Discussion Part 13 (Q121-130, super helpful for Step 2!)
- **Published:**2025-02-01
- Source:Episode page
One-liner
This episode covers diverse clinical scenarios including HPV vaccination protocols, managing symptomatic mitral regurgitation leading to heart failure, classifying pleural effusions using Light's criteria, assessing PKD prognosis, initiating diabetes pharmacotherapy, treating Paget's disease with bisphosphonates, investigating opioid use disorder via urine screening, recognizing hyperthyroidism-induced high-output cardiac failure, and selecting appropriate antibiotics for mastitis/TB management.
High-yield summary
- HPV Vaccination: The vaccine is recommended from age 9 up to age 45. Dosing differs: 2 doses for ages 9–14; 3 doses for ages >14.
- Pleural Effusion Classification (Light's Criteria): An effusion is exudative if any of the following criteria are met: Pleural Fluid Protein/Serum Protein ratio > 0.5, Pleural Fluid LDH/Serum LDH ratio > 0.6, OR Pleural Fluid LDH > 2/3 ULN.
- Heart Failure (Mitral Regurgitation): Symptomatic MR causing volume overload and systolic dysfunction (S3 gallop) requires surgical intervention (valve replacement), regardless of age if EF is dropping or symptoms are present.
- Hyperthyroidism Complication: Excess thyroid hormone increases _1-adrenergic receptors on cardiac myocytes, leading to chronic high cardiac output demand and potentially precipitating High-Output Heart Failure (a form of systolic dysfunction).
- Infection Management: Suspected MRSA in mastitis requires broad coverage, such as IV Vancomycin, due to the patient's risk factors (hospitalization, fever).
- LTBI Treatment: For positive PPD/Tuberculin skin test with negative CXR, treatment is Isoniazid (INH) plus Pyridoxine ({B}_6) for 9 months. {B}_6 supplementation prevents INH-induced peripheral neuropathy.
Learning objectives
- Differentiate between transudative and exudative pleural effusions using Light's criteria.
- Determine the appropriate timing for surgical intervention in symptomatic valvular heart disease.
- Identify the metabolic complications of hyperthyroidism, particularly cardiac strain.
- Select appropriate antibiotic coverage for severe infections (e.g., mastitis) based on risk factors for resistant organisms.
- Initiate prophylactic treatment and monitor side effects for latent tuberculosis infection.